| Today’s Big NewsOct 5, 2023 |
|
The New QPS Therapeutic RNAi White Paper discusses the past, present and future utility of RNAi therapeutics in disease treatments. QPS is the ideal partner to help develop custom-built solutions that forge efficient drug development pathways. Learn more.
 |
|
| By Angus Liu Merck’s Keytruda is riding a winning streak in bladder cancer. Following FDA approvals in the metastatic and non-muscle invasive settings, the anti-PD-1 therapy has delivered a positive readout in muscle-invasive urothelial carcinoma. |
|
|
|
By Annalee Armstrong EQRx charged forward with a mission to develop a catalog of drugs at “radically lower prices." Now, in a regulatory filing, the behind-the-scenes unraveling has been revealed. |
By Conor Hale The Library of Congress has recently become a battleground over the right to repair, including for high-tech imaging machines and surgical robots. |
By Max Bayer AbbVie is exercising its right to buy mitochondria-focused biotech Mitokinin for $110 million upfront. The acquisition gives AbbVie rights to a preclinical Parkinson's candidate. |
|
Thursday, October 12, 2023 | 11am ET / 8am PT A fundamental research question continues to resonate today: How can we proactively develop countermeasures against future viral outbreaks? In this webinar, leaders in industry and academia discuss their experiences using innovative tools to study and develop therapeutics against influenza, SARS-CoV-2, dengue viruses, and more. Register now. 
|
|
By Fraiser Kansteiner Lonza has extended a long-term collaboration with an unnamed “major global biopharmaceutical partner” to crank up commercial supply of antibody-drug conjugates at its site in Visp, Switzerland. The deal is set to boost Lonza’s current bioconjugation capacity fourfold, thanks to the addition of two new bioconjugation suites. |
By Conor Hale Google’s life-science-focused sister company said the Workbench program—which operates as part of its larger Viewpoint offering of evidence generation solutions—was built out of its experiences providing data services to large research projects. |
By Zoey Becker The government will wind down its Lagevrio distribution ahead of the transition, the Administration for Strategic Preparedness and Response said. |
By Andrea Park Two years after its launch as a joint venture between the Mayo Clinic and Nference to develop artificial intelligence algorithms capable of pulling out new insights from routine electrocardiograms, Anumana has earned its first 510(k) clearance from the FDA. |
By James Waldron UniQure is losing a fifth of its employees—including its chief scientific officer—as well half of its R&D projects in a bid to claw back enough money to keep its planned gene therapy trials running into 2027. |
By Kevin Dunleavy Five years after partnering up with Berkshire Sterile Manufacturing, Sharp Services is buying out the fill-finish CDMO for an undisclosed sum. Sharp, a 71-year-old subsidiary of Ireland-based UDG Healthcare, focuses on commercial pharmaceutical packaging and supplies for clinical trials |
By Max Bayer Atsena Therapeutics has cut staff to funnel more money toward an inherited retinal disease program that just began dosing for a phase 1/2 trial in August. |
By Andrea Park Halfway through its fiscal year, Medtronic is finally filling the vacancy at the helm of its neuromodulation operating unit. |
Fierce podcasts Don’t miss an episode |
| In this episode of "The Top Line," Fierce Pharma's Eric Sagonowksy talks with Pam Cheng, the AstraZeneca executive who is playing a key role in driving the company's sustainability ambitions. |
|
|---|
|
|
|
Thursday, October 12, 2023 | 2pm ET / 11am PT In this webinar, we take a deep dive into different strategies for unifying enterprise-wide lab data. You'll learn how to drive better access, collaboration, and AI-driven insight. Don't miss out, register today. 
|
|
Webinar Embark on an in-depth journey through the pivotal Make-Test-Decide Workflow, where collaboration and data-driven decisions play a paramount role in the intricate landscape of drug discovery. Watch now to learn how cloud implementation fosters accessibility and collaboration, revolutionizing research across locations and companies. Sponsored by: Revvity Signals |
eBook Learn how to get better results from suboptimal biospecimens for NGS and protein analysis. Sponsored by: Covaris |
Whitepaper Economic and regulatory factors are making biopharma supply chains more complex in the EU. This paper explores strategies that biopharma companies can use to better manage complexity, cost, and risk. Presented by: AIM, the supply chain leader for life science entrants and midsize life science companies |
Whitepaper From Assay Development Through Large Molecule Development. Streamline your R&D workflows and gain valuable insights with our Biology Solutions Brochure. Download now to discover how to control your laboratory workflows across various assay techniques, modalities, and data types. Sponsored by: Revvity Signals |
eBook Emulate in vivo biology with next-generation in vitro technology. Sponsored by: Emulate |
Whitepaper Learn more about how you can improve the productivity of your research and manufacturing operations and accelerate the journey from laboratory to saving lives. Sponsored by: JLL |
Whitepaper Learn how outsourcing the buffer preparation can reallocate resources to support core activities of your bioprocess production. Sponsored by: Thermo Fisher Scientific |
Whitepaper From trial site feasibility and patient populations to data analysis, generative AI has the potential to revolutionize drug discovery and clinical trial recruitment at both the therapeutic area and indication level. Sponsored by: H1 |
Whitepaper Learn how a GPCR-focused library with a cell-based biopanning strategy led to the discovery of 13 high-affinity and selective anti-GLP-1R antibodies with highly developable therapeutic properties. Sponsored by: Twist Bioscience |
Whitepaper By 2030, the global demand for biologics is projected to grow at a CAGR of 8.7% and the challenges, risks, and costs of bringing large molecule products to market are growing exponentially. Sponsored by: ThermoFisher Scientific |
| |
|
